Walleye Capital
BMY icon

Walleye Capital’s Bristol-Myers Squibb BMY Stock Holding History

Walleye Capital’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.8M Buy
65,900
+12,100
+22% +$695K 0.01% 1001
2026
Q1 		$3.26M Sell
53,800
-385,500
-88% -$22.5M 0.01% 1076
2025
Q4 		$23.7M Buy
439,300
+268,000
+156% +$12.9M 0.07% 234
2025
Q3 		$7.73M Buy
171,300
+9,800
+6% +$458K 0.03% 666
2025
Q2 		$7.48M Buy
161,500
+22,200
+16% +$1.09M 0.03% 643
2025
Q1 		$8.5M Sell
139,300
-79,500
-36% -$4.63M 0.04% 513
2024
Q4 		$12.4M Sell
218,800
-78,100
-26% -$4.36M 0.03% 512
2024
Q3 		$15.4M Sell
296,900
-328,600
-53% -$15.4M 0.03% 459
2024
Q2 		$26M Buy
625,500
+352,200
+129% +$15.8M 0.05% 270
2024
Q1 		$14.8M Sell
273,300
-143,900
-34% -$7.33M 0.03% 581
2023
Q4 		$21.4M Sell
417,200
-35,900
-8% -$1.88M 0.05% 300
2023
Q3 		$26.3M Buy
453,100
+304,700
+205% +$18.7M 0.07% 173
2023
Q2 		$9.49M Buy
148,400
+71,400
+93% +$4.79M 0.03% 424
2023
Q1 		$5.34M Buy
77,000
+12,400
+19% +$875K 0.08% 303
2022
Q4 		$4.65M Sell
64,600
-39,500
-38% -$2.98M 0.08% 283
2022
Q3 		$7.4M Buy
+104,100
New +$7.55M 0.14% 156
2020
Q1 		– Sell
-96,400
Closed -$6.19M – 971
2019
Q4 		$6.19M Buy
96,400
+17,700
+22% +$1.01M 0.4% 28
2019
Q3 		$3.99M Buy
78,700
+37,000
+89% +$1.74M 0.24% 77
2019
Q2 		$1.89M Buy
41,700
+41,000
+5,857% +$1.91M 0.21% 107
2019
Q1 		$33K Buy
+700
New +$34.9K 0.01% 1284

Other funds holding BMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Walleye Capital's BMY Position: Q2 2026 in Review

Walleye Capital increased its Bristol-Myers Squibb (BMY) stake by 23,085% in Q2 2026, buying an estimated $1.03M and bringing the position to 18,084 shares worth $1.04M. The position accounts for ﹤0.01% of the portfolio, ranked #2081.

Walleye Capital first reported a position in BMY in Q1 2019 and has held it in 18 quarters since. The position peaked at $13M in Q3 2023. 2,523 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Walleye Capital held 18,084 shares of Bristol-Myers Squibb worth $1.04M as of Q2 2026.
  • Walleye Capital bought 18,006 Bristol-Myers Squibb shares in Q2 2026, an estimated $1.03M.
  • Bristol-Myers Squibb made up ﹤0.01% of Walleye Capital's portfolio in Q2 2026, its #2081 holding.
  • Walleye Capital first reported a position in Bristol-Myers Squibb in Q1 2019 and has held it in 18 quarters since.
  • Walleye Capital's Bristol-Myers Squibb position peaked at $13M in Q3 2023.
  • 2,523 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.